newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Proposed Public Offering of Common Stock

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced that it intends to offer and sell $100.0 million of shares of its common stock in an underwritten pu